Cargando…

Different interpretations of the CheckMate-227 trial in non-small-cell lung cancer

Detalles Bibliográficos
Autor principal: Su, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260424/
https://www.ncbi.nlm.nih.gov/pubmed/32490280
http://dx.doi.org/10.1016/j.conctc.2020.100578
_version_ 1783540310141304832
author Su, Zheng
author_facet Su, Zheng
author_sort Su, Zheng
collection PubMed
description
format Online
Article
Text
id pubmed-7260424
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-72604242020-06-01 Different interpretations of the CheckMate-227 trial in non-small-cell lung cancer Su, Zheng Contemp Clin Trials Commun Article Elsevier 2020-05-23 /pmc/articles/PMC7260424/ /pubmed/32490280 http://dx.doi.org/10.1016/j.conctc.2020.100578 Text en © 2020 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Su, Zheng
Different interpretations of the CheckMate-227 trial in non-small-cell lung cancer
title Different interpretations of the CheckMate-227 trial in non-small-cell lung cancer
title_full Different interpretations of the CheckMate-227 trial in non-small-cell lung cancer
title_fullStr Different interpretations of the CheckMate-227 trial in non-small-cell lung cancer
title_full_unstemmed Different interpretations of the CheckMate-227 trial in non-small-cell lung cancer
title_short Different interpretations of the CheckMate-227 trial in non-small-cell lung cancer
title_sort different interpretations of the checkmate-227 trial in non-small-cell lung cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260424/
https://www.ncbi.nlm.nih.gov/pubmed/32490280
http://dx.doi.org/10.1016/j.conctc.2020.100578
work_keys_str_mv AT suzheng differentinterpretationsofthecheckmate227trialinnonsmallcelllungcancer